Alexander (Alex) Kasparie has experience in a wide array of matters, ranging from securities and complex commercial litigation to investigations involving the SEC, FINRA and DOJ.
Mr. Kasparie focuses his practice on representing product manufacturers in purported class actions, multidistrict litigation and mass tort proceedings in federal and state courts. As part of that practice, he has drafted numerous Daubert briefs seeking the exclusion of plaintiffs’ experts, as well as a variety of dispositive motions and appellate briefs on the merits. He also has assisted on the development and implementation of strategies to defeat product liability litigation on the merits, including by working with experts to challenge plaintiffs’ scientific and regulatory theories. In particular, Mr. Kasparie has been significantly involved in developing expert evidence and challenging plaintiffs’ experts’ opinions at the Daubert stage in ongoing multidistrict litigation involving a generic pharmaceutical manufacturers’ products.
He also maintains a robust pro bono practice, representing clients in matters at all levels before state and federal courts, including assisting on the submission of multiple amicus briefs to the U.S. Supreme Court and Illinois Supreme Court (on behalf of a criminal justice reform organization) and providing other legal aid.
Prior to rejoining Skadden, Mr. Kasparie served as a law clerk for the Hon. Joel M. Flaum of the U.S. Court of Appeals for the Seventh Circuit and the Hon. Robert M. Dow, Jr. of the U.S. District Court for the Northern District of Illinois.
Representative cases include:
- a medical devices company in connection with multiple SEC, FINRA and DOJ investigations
- a generic pharmaceutical manufacturer in multidistrict litigation seeking over $1 billion in purported damages
- a Fortune 500 pharmaceutical company in state attorneys general enforcement actions and consumer class actions, including the successful appeal of a state trial court’s denial of a motion to rescue
- a direct appeal to the U.S. Court of Appeals for the Seventh Circuit seeking the reversal of a defendant’s sentence
- a medical devices company in connection with an appeal to a state appellate court that resulted in the affirmance of the trial court’s dismissal of the plaintiffs’ claims with prejudice
- a bank and its officers and directors in a federal securities fraud class action, as well as a related derivative class action against the officers and directors